Become a digitalPLUS subscriber. 99 for 4 weeks.

Topics

U.S. Army
Profectus gets more investment for Ebola vaccine, from U.S. Army
Profectus gets more investment for Ebola vaccine, from U.S. Army

The U.S. Army is giving Profectus BioSciences $8.5 million to put toward human trials of the Ebola virus vaccine, bringing the Baltimore biotechnology company's fundraising total for the project to more than $17 million in a matter of days. Profectus had announced last week a grant worth up to $8.6 million for the vaccine from a branch of the U.S. Department of Health and Human Services. The company has drawn nearly $30 million in investment for the project since 2012, all but $5 million of it since the current Ebola outbreak began in West Africa. "Advancing this vaccine into human studies is a top priority for Profectus, and we remain committed to moving this program into...

Loading